A detailed history of Rollins Financial Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rollins Financial Advisors, LLC holds 1,728 shares of JNJ stock, worth $268,704. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,728
Previous 2,135 19.06%
Holding current value
$268,704
Previous $312 Million 10.26%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $59,210 - $68,123
-407 Reduced 19.06%
1,728 $280 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $159,973 - $174,820
-1,108 Reduced 34.17%
2,135 $312 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $30,733 - $32,222
-198 Reduced 5.75%
3,243 $513 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $501,009 - $546,706
3,441 New
3,441 $539 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Rollins Financial Advisors, LLC Portfolio

Follow Rollins Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rollins Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rollins Financial Advisors, LLC with notifications on news.